Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAIN-3: Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer
NCT03820063Phase 2Active, not recruiting
- Sponsor
- Borstkanker Onderzoek Groep
- Start
- Feb 2019
- Primary completion
- Nov 2022
- Modality
- Antibody Conjugates, DNA Intercalators/Alkylators, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection, trastuzumab, carboplatin, pertuzumab in breast cancer, sponsored by Borstkanker Onderzoek Groep. Started Feb 2019; status: active, not recruiting.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03820063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03820063.